Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
14,033,333
-
Total 13F shares
-
12,415,909
-
Share change
-
-75,664
-
Total reported value
-
$473,859,149
-
Put/Call ratio
-
46%
-
Price per share
-
$38.16
-
Number of holders
-
149
-
Value change
-
-$1,414,918
-
Number of buys
-
84
-
Number of sells
-
53
Institutional Holders of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) as of Q4 2015
As of 31 Dec 2015,
Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) was held by
149 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,415,909 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, THOMPSON SIEGEL & WALMSLEY LLC, BlackRock Fund Advisors, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, BTIM Corp., Portolan Capital Management, LLC, AMI ASSET MANAGEMENT CORP, BlackRock Institutional Trust Company, N.A., and HealthInvest Partners AB.
This page lists
149
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.